Share price
$1.21
As of Apr 29, 2026
PLRX | NASDAQ
Pliant Therapeutics, Inc. (PLRX) | runway 9.7 months | financing risk elevated | market cap $74.9M. Daily snapshot of financials, capital pressure, and recen...
Share price
$1.21
As of Apr 29, 2026
Market cap
$74.9M
Snapshot valuation
30D volume
512,787 shares
Rolling average daily volume
Runway
9.7 months
Estimated from precomputed burn and cash
Financing risk
N/A
Current liquidity and financing setup suggest the company may need fresh capital in the near term.
Runway: 9.7 months based on estimated burn.
Financing signal: Current liquidity and financing setup suggest the company may need fresh capital in the near term.
Latest development: PLIANT THERAPEUTICS, INC. 8-K 2026-04-17.
8-K filed on 2026-04-17.
8-K filed on 2026-03-30.
S-3 filing submitted on 2026-03-30.
10-K filed on 2026-03-11.
8-K filed on 2026-03-11.
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
PLIANT THERAPEUTICS, INC. 8-K 2026-04-17
8-K filed on 2026-04-17.
PLIANT THERAPEUTICS, INC. 8-K 2026-03-30
8-K filed on 2026-03-30.
PLIANT THERAPEUTICS, INC. S-3 2026-03-30
S-3 filing submitted on 2026-03-30.
PLIANT THERAPEUTICS, INC. 10-K 2026-03-11
10-K filed on 2026-03-11.
Premium analysis
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.